These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26412462)

  • 1. Secondary prevention: a new era for postpartum haemorrhage?
    Weeks AD
    BJOG; 2016 Jan; 123(1):128. PubMed ID: 26412462
    [No Abstract]   [Full Text] [Related]  

  • 2. Misoprostol for primary versus secondary prevention of postpartum haemorrhage: a cluster-randomised non-inferiority community trial.
    Raghavan S; Geller S; Miller S; Goudar SS; Anger H; Yadavannavar MC; Dabash R; Bidri SR; Gudadinni MR; Udgiri R; Koch AR; Bellad MB; Winikoff B
    BJOG; 2016 Jan; 123(1):120-7. PubMed ID: 26333044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postpartum bleeding is reduced with sublingual powdered misoprostol when compared with oxytocin injection, but a new formulation of misoprostol is unlikely to revolutionise postpartum haemorrhage care.
    Winikoff B; Durocher J
    Evid Based Med; 2013 Aug; 18(4):143-4. PubMed ID: 23125238
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of oral misoprostol in the prevention of postpartum haemorrhage.
    el-Refaey H; O'Brien P; Morafa W; Walder J; Rodeck C
    Br J Obstet Gynaecol; 1997 Mar; 104(3):336-9. PubMed ID: 9091012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: Al-Sawaf A, El-Mazny A, Shohayeb A. 2013. A randomised controlled trial of sublingual misoprostol and intramuscular oxytocin for prevention of postpartum haemorrhage. Journal of Obstetrics and Gynaecology 33:277-279.
    Rani S; Huria A
    J Obstet Gynaecol; 2013 Oct; 33(7):751. PubMed ID: 24127978
    [No Abstract]   [Full Text] [Related]  

  • 6. Post-partum haemorrhage: beyond the confrontation between misoprostol and oxytocin.
    Buekens P; Althabe F
    Lancet; 2010 Jan; 375(9710):176-8. PubMed ID: 20109901
    [No Abstract]   [Full Text] [Related]  

  • 7. Misoprostol for the management of postpartum bleeding: a new approach.
    Dabash R; Blum J; Raghavan S; Anger H; Winikoff B
    Int J Gynaecol Obstet; 2012 Dec; 119(3):210-2. PubMed ID: 22980431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should we be using misoprostol to prevent postpartum haemorrhage?
    Pract Midwife; 2013 May; 16(5):9. PubMed ID: 23789247
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of postpartum hemorrhage with misoprostol.
    International Federation Of Gynecology and Obstetrics
    Int J Gynaecol Obstet; 2012 Dec; 119(3):213-4. PubMed ID: 23022109
    [No Abstract]   [Full Text] [Related]  

  • 10. Rectal misoprostol vs. 15-methyl prostaglandin F2alpha for the prevention of postpartum hemorrhage.
    Nellore V; Mittal S; Dadhwal V
    Int J Gynaecol Obstet; 2006 Jul; 94(1):45-6. PubMed ID: 16764879
    [No Abstract]   [Full Text] [Related]  

  • 11. A report from #BlueJC: should oral misoprostol be used in home births in low-resource countries?
    Hussein J; Leung EY
    BJOG; 2013 Aug; 120(9):1156-7. PubMed ID: 23837782
    [No Abstract]   [Full Text] [Related]  

  • 12. Preventing primary postpartum hemorrhage in unskilled births in Africa.
    Udofia I; Okonofua F
    Afr J Reprod Health; 2008 Aug; 12(2):7-13. PubMed ID: 20695039
    [No Abstract]   [Full Text] [Related]  

  • 13. [Reduced post-partum bleeding after treatment with sublingual misoprostol: a randomized double-blind clinical study in a developing country--secondary publication)].
    Nielsen BB; Høj L; Hvidman LE; Nielsen J; Cardoso P; Aaby P
    Ugeskr Laeger; 2006 Mar; 168(13):1341-3. PubMed ID: 16579891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of misoprostol in third stage of labour.
    O'Brien P; Lokugamage AU; Guillebaud J; Rodeck CH
    Lancet; 2002 Feb; 359(9307):708; author reply 709-10. PubMed ID: 11879891
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of misoprostol in third stage of labour.
    El-ReFaey H
    Lancet; 2002 Feb; 359(9307):707-8; discussion 709-10. PubMed ID: 11879890
    [No Abstract]   [Full Text] [Related]  

  • 16. Questions raised over use of misoprostol to prevent postpartum haemorrhage in poor countries.
    Torjesen I
    BMJ; 2012 Aug; 345():e5715. PubMed ID: 22932982
    [No Abstract]   [Full Text] [Related]  

  • 17. Oxytocin via Uniject (a prefilled single-use injection) versus oral misoprostol for prevention of postpartum haemorrhage at the community level: a cluster-randomised controlled trial.
    Diop A; Daff B; Sow M; Blum J; Diagne M; Sloan NL; Winikoff B
    Lancet Glob Health; 2016 Jan; 4(1):e37-44. PubMed ID: 26718808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised placebo controlled trial of oral misoprostol in the third stage of labour.
    Hofmeyr GJ; Nikodem VC; de Jager M; Gelbart BR
    Br J Obstet Gynaecol; 1998 Sep; 105(9):971-5. PubMed ID: 9763047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrauterine misoprostol for the treatment of severe recurrent atonic secondary postpartum haemorrhage.
    Adekanmi OA; Purmessur S; Edwards G; Barrington JW
    BJOG; 2001 May; 108(5):541-2. PubMed ID: 11368143
    [No Abstract]   [Full Text] [Related]  

  • 20. Misoprostol for prevention and treatment of postpartum hemorrhage: what do we know? What is next?
    Raghavan S; Abbas D; Winikoff B
    Int J Gynaecol Obstet; 2012 Oct; 119 Suppl 1():S35-8. PubMed ID: 22883912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.